NDC 63323-117-01 - Fluorouracil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-117
- Requested NDC
- 63323-117-01
- Package NDCs from labels
- 63323-117-51, 63323-117-61, 63323-117-59, 63323-117-69, 63323-117-43, 63323-117-18, 63323-117-41, 63323-117-28, 63323-117-58, 63323-117-68, 63323-117-00, 63323-117-10, 63323-117-01, 63323-117-20, 63323-117-31, 63323-117-19
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2026-07-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fluorouracil - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-07-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluorouracil - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-06-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluorouracil - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-06-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluorouracil - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluorouracil - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-03-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluorouracil - ProPharma Distribution | ProPharma Distribution | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluorouracil - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-06-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-117-00 | Fluorouracil | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 10 | |
| 63323-117-01 | Fluorouracil | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 10 | |
| 63323-117-10 | Fluorouracil | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 10 | |
| 63323-117-20 | Fluorouracil | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 10 | |
| 63323-117-51 | Fluorouracil | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 6 | |
| 63323-117-51 | Fluorouracil | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION, SOLUTION | 50 | 6 | |
| 63323-117-61 | Fluorouracil | 100 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION, SOLUTION | 100 | 6 | |
| 63323-117-61 | Fluorouracil | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 6 | |
| 63323-117-18 | Fluorouracil | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 5 | |
| 63323-117-19 | Fluorouracil | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 5 | |
| 63323-117-28 | Fluorouracil | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 5 | |
| 63323-117-31 | Fluorouracil | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 5 | |
| 63323-117-41 | Fluorouracil | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 5 | |
| 63323-117-43 | Fluorouracil | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 5 | |
| 63323-117-58 | Fluorouracil | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION, SOLUTION | 50 | 5 | |
| 63323-117-58 | Fluorouracil | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 5 | |
| 63323-117-68 | Fluorouracil | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 5 | |
| 63323-117-68 | Fluorouracil | 100 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION, SOLUTION | 100 | 5 | |
| 63323-117-59 | Fluorouracil | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 4 | |
| 63323-117-59 | Fluorouracil | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION, SOLUTION | 50 | 4 | |
| 63323-117-69 | Fluorouracil | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 4 | |
| 63323-117-69 | Fluorouracil | 100 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION, SOLUTION | 100 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-117 | FLUOROURACIL INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 8 | Current NDC, Legacy NDC, 4 package rows | 20241013_c45f5286-a52b-43e5-8a6f-d0312e7da0c8.zip |
| 63323-117 | FLUOROURACIL INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 4 package rows | 20250129_21af1777-87f7-4e40-9917-f1677e7ff1a5.zip |
| 63323-117 | FLUOROURACIL INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 4 package rows | 20241122_beb8c6c5-4b6e-4770-b6d4-718e33c7a2ff.zip |
| 63323-117 | FLUOROURACIL INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 4 package rows | 20241013_a85ab26a-05ea-498f-8f34-564a925fa9d9.zip |
| 63323-117 | FLUOROURACIL INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20241013_fdf2a165-2ca4-48be-89c1-570e6010b47c.zip |
| 63323-117 | FLUOROURACIL INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 4 package rows | 20250129_b4328ae3-f48f-40b1-9719-1c1aced7c734.zip |
DailyMed Billing Units#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
| Fluorouracil | FLUOROURACIL | Gland Pharma Limited | 572b710e-8e2b-46eb-bd80-648ad769d34d | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 1791736 1791701 U3P01618RT |
| Fluorouracil | FLUOROURACIL | Gland Pharma Limited | ea3497db-23b9-4ace-9a6f-b54853d04a82 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 239177 U3P01618RT |
| Fluorouracil | FLUOROURACIL | ProPharma Distribution | 43057fcd-1f87-cc1a-e063-6294a90a8d24 | 2025-11-07 | Warnings, Adverse reactions | ANDA040279 84549-117-10 84549-117 1791701 43057fcd-1f86-cc1a-e063-6294a90a8d24 43057fcd-1f87-cc1a-e063-6294a90a8d24 U3P01618RT |
| STERILE WATER | WATER | Henry Schein, Inc. | f4087143-9868-4308-b96c-43657ee8ec28 | 2025-11-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.